Related Experiment Video

Updated: Jul 11, 2026

Analysis of the Epithelial Damage Produced by Entamoeba histolytica Infection
11:49

Analysis of the Epithelial Damage Produced by Entamoeba histolytica Infection

Published on: June 12, 2014

[UltrastructuraL analysis of the action of levorin on Entamoeba]

K O Ovnanian, L K Liubimova, L N Ivanova

    Antibiotiki I Meditsinskaia Biotekhnologiia = Antibiotics and Medical Biotechnology
    |December 1, 1987
    PubMed

    More Related Videos

    Measuring Caenorhabditis elegans Sensitivity to the Acetylcholine Receptor Agonist Levamisole08:11

    Measuring Caenorhabditis elegans Sensitivity to the Acetylcholine Receptor Agonist Levamisole

    Published on: June 7, 2022

    Determining Intestinal Permeability Using Lucifer Yellow in an Apical-Out Enteroid Model09:48

    Determining Intestinal Permeability Using Lucifer Yellow in an Apical-Out Enteroid Model

    Published on: July 27, 2022

    Related Concept Videos

    Amebiasis01:28

    Amebiasis

    Entamoeba histolytica, a protozoan parasite, is responsible for intestinal and extraintestinal amebiasis. Though a significant proportion of infections remain asymptomatic, approximately 50 million individuals annually are estimated to present with clinical disease, resulting in up to 100,000 deaths globally. The disease burden is disproportionately high in regions with lower socioeconomic status, such as parts of India, Africa, Mexico, and Latin America.Etiology and TransmissionThe infective...
    Anthelminthic Agents01:15

    Anthelminthic Agents

    Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...
    Antiprotozoal Agents01:21

    Antiprotozoal Agents

    Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...